Der DemTect in der klinischen Anwendung
Sensitivität und Spezifität eines kognitiven Screeninginstruments
Abstract
Zusammenfassung: Kognitive Screeningtests sind hilfreiche Instrumente zur Unterstützung der Demenzdiagnose. Der im Jahr 2000 eingeführte DemTect stellt ein im deutschsprachigen Raum mittlerweile vielfach angewendetes Screeningverfahren dar, das mit dem Ziel entwickelt wurde, möglichst sensitiv zu sein und damit Demenzen in Frühstadien sowie leichte kognitive Störungen (Mild Cognitive Impairment, MCI) erkennen zu können. In diesem Beitrag werden bisherige Befunde zur Anwendung des DemTects bei verschiedenen Indikationen unter besonderer Berücksichtigung der Frage nach Sensitivität und Spezifität des Verfahrens dargestellt und weiterer Forschungsbedarf aufgezeigt. Zusammenfassend hat sich der DemTect bislang sowohl im Rahmen der Diagnostik von Demenzsyndromen unterschiedlicher Ätiologie - Alzheimer Demenz und vaskuläre Demenz - als auch bei Patienten mit MCI bewährt. Erste positive Ergebnisse zur Anwendbarkeit bei dementen Parkinsonpatienten liegen ebenfalls vor. In allen Studien zeichnet sich der DemTect durch eine besonders hohe Sensitivität für demenzassoziierte kognitive Störungen aus. Eine entsprechende Empfehlung des Verfahrens wurde auch in die deutschen Richtlinien zur Diagnose und Therapie der Alzheimer Demenz und Demenz mit Lewy-Körperchen aufgenommen.
Summary: Cognitive screening tests are helpful instruments to support the diagnosis of dementia. The DemTect, introduced in 2000, is a screening instrument that is nowadays frequently used in German speaking countries; an English version also exists. The main goal of its development was a high sensitivity to detect patients with dementia in early stages of the disease and also patients with mild cognitive impairment. In this article, we present results regarding the clinical use of the DemTect in different groups of patients with a special focus on its sensitivity and specificity. In summary, the DemTect is effective in screening for patients with dementias of different etiology - Alzheimer's disease and vascular dementia - and also in patients with mild cognitive impairment. Preliminary but positive results also exist for patients with Parkinson's disease and dementia. In all studies the DemTect was highly sensitive for dementia-related cognitive dysfunction. Accordingly, the DemTect is recommended as a cognitive screening test in the German guidelines for diagnosis and therapy of Alzheimer dementia and dementia with Lewy bodies.
References
1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author
(2002). Test performance in dementia screenings are influenced by age but not by education and profession - new data of the DemTect. Neurorehabilitation and Neural Repair, 15, 301–
(2002). CD-ROM: DemTect zur Unterstützung der Demenz-Diagnostik . Frankfurt: Eisai
(2004). Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology, 62, 556– 562
(2001). Patterns of cognitive decline in presymptomatic Alzheimer disease: A prospective community study. Archives of General Psychiatry, 58, 853– 858
(1992). Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology, 42, 473– 480
(2002). An analysis of systems of classifying mild cognitive impairment in older people. Australian and New Zealand Journal of Psychiatry, 36, 133– 140
(2004). The one-minute mental status examination. Neurology, 62, 534– 535
(1994). The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308– 2314
(2004). The neuropsychology of vascular cognitive impairment: Is there a specific cognitive deficit?. Journal of the Neurological Sciences, 226, 3– 7
(2005). Leitlinien für Diagnostik und Therapie in der Neurologie. Herausgegeben von der Komission “Leitlinien der Deutschen Gesellschaft für Neurologie (3. Aufl.). Stuttgart: Thieme
(1996). Die Entwicklung der Demenz bis zum Jahr 2050. Gesundheitswesen, 58 (Sonderheft 1), 50– 55
(2004). Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment. Journal of Molecular Neuroscience, 24, 33– 44
(1975). Mini-Mental-State - a practical method for grading the cognitive state of patients for the clinician. International Journal of Methods in Psychiatric Research, 12, 189– 198
(2001). Alzheimer-Demenz. In H. Förstl (Hrsg.), Demenzen in Theorie und Praxis (S. 4361). Berlin: Springer
(1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566– 572
(2000). Entwicklung und Validierung eines Tests zur Früherkennung der Demenz mit Depressionsabgrenzung. Fortschritte der Neurologie, Psychiatrie, 68, 413– 422
(2003). The Rapid Dementia Screening Test (RDST): A new economical tool for detecting possible patients with dementia. Dementia and Geriatric Cognitive Disorders, 16, 193– 199
(2004). DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. International Journal of Geriatric Psychiatry, 19, 136– 143
(2003). Improvements of cognition and activities of daily living in galantamine-treated patients with probable Alzheimer's disease: A large-scale observational study. Journal of Neurology, 10(1), 160–
(2002). DemTect: A new screening instrument with very high sensitivity for vascular and Alzheimer dementia. In A.D. Korczyn (Ed.), 2nd international congress on vascular dementia. Bologna: Monduzzi Editore
(2000). DemTect: Ein neues Screening-Verfahren zur Unterstützung der Demenzdiagnostik. Psycho, 26, 243– 347
(1997). Gedächtnisstörungen im Alter: Prodrom einer Demenz?. In S. Weis & G. Weber (Eds.), Handbuch Morbus Alzheimer. Weinheim: Psychologie Verlags Union
(2003). Reminyl improves cognition and memory within 90 days in Alzheimer patients. Journal of Neurology, 250 (2), II/128–
(1990). Der Mini Mental Status Test . Weinheim: Beltz-Test
(1997). The impact of aging on cognitive functions. An 11 year follow-up study of four age cohorts. Acta Neurology Scandinavica, 172, 7– 86
(2005). Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase, 11, 65– 71
(1999). Report of the second dementia with Lewy body international workshop: Diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology, 53, 902– 905
(1999). Lack of prognostic significance of SPECT abnormalities in elderly subjects with a mild memory loss. Canadian Journal of Neurological Sciences, 26, 23– 28
(1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939– 944
(1996). Neuropsychological aspects of vascular dementia. Brain, 31, 269– 282
(2004). The seven minute screen: A neurocognitive screening test highly sensitive to various types of dementia. Journal of Neurology, Neurosurgery and Psychiatry, 75, 700– 705
(1995). Improving the diagnostic accuracy of the Mini Mental State Examination. Acta Neurology Scandinavica, 92, 145– 150
(1998). Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology, 51, 1546– 1554
(2004). Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Movement Disorders, 19, 60– 67
(2003). Die Eignung einfacher klinischer Tests für die Erkennung der leichten kognitiven Störung und der leichtgradigen Demenz. Aktuelle Neurologie, 30, 114– 117
(2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183– 194
(2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985– 1992
(2003). Clinical features. In R.C. Petersen (Ed.), Mild cognitive impairment: Clinical characterization and outcome (S. 15-40). New York: Oxford University Press
(1999). Mild Cognitive Impairment: Clinical characterization and outcome. Archives of Neurology, 56, 303– 308
(2002). Mikro-Mental-Test. Ein Kurzverfahren zum Demenzscreening. Der Nervenarzt, 73, 839– 844
(1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250– 260
(2000). Clock-drawing: Is it the ideal cognitive screening test?. Journal of Geriatric Psychiatry, 15, 548– 561
(1998). A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Archives of Neurology, 55, 349– 355
(2000). Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Value of the Mini-Mental State Examination. Archives of Family Medicine, 9, 527– 532
(1992). The mini-mental state examination: a comprehensive review. Journal of the American Geriatric Society, 40, 922– 935
(2004). DemTect effective in screening for mild cognitive impairment and mild dementia. Evidence-Based Mental Health, 7, 70–
(1998). The prognosis of mild cognitive impairment in the elderly. Journal of Neural Transmission, 54, 31– 50
(2002). Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes. International Journal of Geriatric Psychiatry, 17, 1027– 1033
(2001). Leichte kognitive Beeinträchtigungen im Alter. In H. Förstl, (Hrsg.), Demenzen in Theorie und Praxis (S. 23-42). Berlin: Springer-Verlag
(